Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > The Never Ending Cycle

<< Previous

Bullboard Posts

Next >>

Comment by StableGenius97on Oct 07, 2020 12:39pm

158 Views

Post# 31680446

RE:The Never Ending Cycle

Step 1 Catalyst list posted on Message board for the year
Step 2 Catalyst A comes to fruiting
Step 3 Company creats horrible presentation and fails to capitalize
Step 4 No enthusiam is created stock price falls
Step 5 SPCEO calls analysts dumb and says we need new coverage which never happens
Step 6 stock price falls some more and the company moves on to the "next big thing"
Step 7 wow a new catalyst thats even bigger than the last one lets try this again
Step 8 repeat step 2 - 7

<< Previous

Bullboard Posts

Next >>

Nextech CEO provides company update on Amazon deal and more